As evidence of concurrent stress conditions, we demonstrate increased expression of ATF4, a master regulatory protein of the integrated stress response (ISR) pathway in OLs in active MS lesions while expression of the mTOR pathway marker p4E-BP1 is reduced. The gene discussed is ATF4; the disease is myeloid sarcoma.